Recommendations for clinical decision-making when offering exoskeletons for community use in individuals with spinal cord injury

Recommendations for clinical decision-making when offering exoskeletons for community use in individuals with spinal cord injury

Approved in 2014 by the Food and Drug Administration (FDA) for use with a trained companion, personal powered exoskeletons (PPE) for individuals with spinal cord injury (SCI) provide an opportunity for the appropriate candidate to ambulate in their home and community. As an adjunct to wheeled mobili...

Full description

Bibliographic Details
Main Authors: Derrick Onate, Cassandra Hogan, Kathryn Fitzgerald, Kevin T. White, Keith Tansey
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-08-01
Series:Frontiers in Rehabilitation Sciences
Subjects:
personal powered exoskeleton
mobility
community ambulation
quality of life
spinal cord injury
Online Access:https://www.frontiersin.org/articles/10.3389/fresc.2024.1428708/full

Internet

https://www.frontiersin.org/articles/10.3389/fresc.2024.1428708/full

Similar Items